FISCAL NOTE
Date Requested: January 14, 2023
Time Requested: 02:59 PM |
| Agency: |
Insurance Commission |
|---|
| CBD Number: |
Version: |
Bill Number: |
Resolution Number: |
| 1273 |
Introduced |
HB2086 |
|
|---|
| CBD Subject: |
|
|---|
|
FUND(S):
7152 OIC Operating Fund
Sources of Revenue:
Special Fund
Legislation creates:
Fiscal Note Summary
Effect this measure will have on costs and revenues of state government.
The purpose of House Bill 2086 is to increase the number of pain management visits insurance companies must cover under the opioid reduction act.
House Bill 2086, if enacted, would have no fiscal impact on the Offices of the Insurance Commissioner.
Please see the memorandum section of this fiscal note for additional information.
Fiscal Note Detail
| Effect of Proposal |
Fiscal Year |
2023
Increase/Decrease
(use"-") |
2024
Increase/Decrease
(use"-") |
Fiscal Year
(Upon Full
Implementation) |
| 1. Estmated Total Cost |
0 |
0 |
0 |
| Personal Services |
0 |
0 |
0 |
| Current Expenses |
0 |
0 |
0 |
| Repairs and Alterations |
0 |
0 |
0 |
| Assets |
0 |
0 |
0 |
| Other |
0 |
0 |
0 |
| 2. Estimated Total Revenues |
0 |
0 |
0 |
Explanation of above estimates (including long-range effect):
Please explain increases and decreases in personal services, current expenses, repairs and alterations, assets, other costs and revenues, including assumptions and data sources and delineation between start-up and ongoing costs. Please also include a long-range schedule of costs and revenues if fiscal impact is expected to vary in future years.
Memorandum
House Bill 2086, if enacted, would increase the number of pain management visits insurance companies must cover under the opioid reduction act.
House Bill 2086 would have no fiscal impact on the operations, expenses, or revenues of the Offices of the Insurance Commissioner.
PEIA and DHHR should be consulted regarding the fiscal impact to their agencies.
It should be noted that House Bill 2086 does not contain language limiting the insurance benefits provided under the bill to the essential health benefits (EHB) specified under section 130(b) of the Patient Protection and Affordable Care Act (PPACA).
PPACA 1311(d)(3) provides that a state must defray the cost by direct payment to the enrollees or to the Plan of any state mandated benefit in excess of the EHB. To the extent that the health insurance benefits required by HB2086 do not fall within the EHB, a potential cost to the State exists.
Person submitting Fiscal Note: Cheri Harpold
Email Address: cheri.a.harpold@wv.gov